Detalles de la búsqueda
1.
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer.
Dermatology
; 237(6): 929-933, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33508823
2.
The importance of integrated therapies on cancer: Silibinin, an old and new molecule.
Oncotarget
; 15: 345-353, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38781107
3.
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study).
Cancers (Basel)
; 13(9)2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33925278
4.
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives.
Expert Rev Anticancer Ther
; 20(7): 531-542, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32529917
5.
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
Eur J Cancer
; 135: 159-169, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32580131
6.
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis.
Immunotherapy
; 11(10): 921-930, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31155995
7.
[Current approaches to the first-line treatment of clear-cell renal cell carcinoma]. / Approccio al trattamento di prima linea del carcinoma renale a cellule chiare metastatico.
Recenti Prog Med
; 106(8): 370-9, 2015 Aug.
Artículo
en Italiano
| MEDLINE | ID: mdl-26228864
8.
Beyond Primary Tumor Location and RAS/BRAF Mutational Status as Prognostic Factor in Stage III Colon Cancer.
JAMA Oncol
; 4(9): 1297-1298, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30003239
Resultados
1 -
8
de 8
1
Próxima >
>>